St Jude CE-marks cardiac ICD (implantable cardioverter defibrillator) and pacemaker devices:
This article was originally published in Clinica
Executive Summary
St Jude Medical has gained the European go-ahead to sell both its rate-adaptive Atlas DR/VR implantable cardioverter defibrillator (ICD) and its Identity pacemaker devices for the treatment of patients with cardiac rhythm abnormalities. The Atlas ICD device, which is implanted under the skin, can deliver several magnitudes of electrical shock to patients with ventricular tachycardia and fibrillation. Separately, the Identity pacemaker device has both a therapeutic and diagnostic capability for pacemaker patients suffering from atrial fibrillation, said the St Paul, Minnesota firm.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.